Trial intelligence / Profile preview

Lactobacillus reuteri as Adjunct to SRP in Chronic Periodontitis

NCT04697199Phase 1Completed

Sponsor
Tanta University
Start
Sep 2018
Primary completion
Sep 2019
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of lactobacillus reuteri in chronic periodontitis (2 arms), sponsored by Tanta University. Primary endpoint: Probing Pocket Depth at 6 months. Started Sep 2018; status: completed.

02

Drugs

lactobacillus reuteri
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT04697199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04697199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call